The present invention provides a method for preventing or treating inflammatory skin conditions, by administering a composition comprising at least one milk derived protein. The present invention further relates to a method for moisturizing dry skin, skin softening, reducing skin itching, reducing skin peeling, reducing skin redness, reducing rough skin, reducing skin swelling, reducing skin cracking, renewal skin cells, preserving hand skin or any combination thereof.
The current disclosure relates to a method of increasing milk quality in lactating mammals comprising administering a composition comprising at least one casein derived peptide.
A23C 9/00 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre
A23C 9/12 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes
A23C 9/142 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
A23C 9/20 - Produits diététiques à base de lait non couverts par les groupes
A23C 19/05 - Traitement du lait avant le caillageSéparation du petit-lait du lait caillé
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du lait, p. ex. caséinePréparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C07K 5/103 - Tétrapeptides la chaîne latérale du premier amino-acide étant acyclique, p. ex. Gly, Ala
C07K 5/11 - Tétrapeptides la chaîne latérale du premier amino-acide contenant plus de groupes amino que de groupes carboxyle, ou leurs dérivés, p. ex. Lys, Arg
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
A23K 10/10 - Produits alimentaires pour animaux obtenus par des procédés microbiologiques ou biochimiques
A23K 10/20 - Produits alimentaires pour animaux à base de matières d’origine animale
A23K 20/147 - Dérivés polymériques, p. ex. peptides ou protéines
A23K 50/10 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les ruminants
3.
COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS
The present disclosure provides compositions and methods for modulating various mammary' disorders and conditions. The disclosure further provides a therapeutic combination of a composition of at least one casein protein or casein-derived peptide; and a teat seal composition.
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
A61K 38/10 - Peptides ayant de 12 à 20 amino-acides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
4.
COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS
The present invention provides compositions and methods for treating intramammary infection in lactating mammals during lactation and providing a continuous milk production and milking in lactating mammals during lactation, wherein somatic cell count in milk, milk electrical conductivity or combination thereof are increased.
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Intramammary and intrauterine veterinary preparations;
intramammary and intrauterine pharmaceutical and medical
preparations for human use; pharmaceutical preparations,
veterinary preparations, and medical preparations for the
treatment and prevention of mastitis, breast inflammation,
mammary infections, and mammary disorders; pharmaceutical
preparations, veterinary preparations, and medical
preparations for the treatment and prevention of metritis;
pharmaceutical preparations, veterinary preparations, and
medical preparations for the prevention and treatment of
uterine infections; veterinary preparations for increasing
milk production and improving feed efficiency; animal feed
additive for use as a nutritional supplement for medical
purposes; pharmaceutical and medical preparations for
increasing milk production; veterinary preparations for the
prevention and treatment of bacterial infections, disorders,
conditions, and diseases; pharmaceutical preparations and
medical preparations for the prevention and treatment of
bacterial infections, disorders, conditions, and diseases;
pharmaceutical preparations, veterinary preparations and
medical preparations for the involution of the udder or the
mammary gland; pharmaceutical preparations, veterinary
preparations and medical preparations for reduction of
somatic cell count; veterinary preparations, and
pharmaceutical preparations for increasing the welfare and
comfort of lactating animals, namely, to reduce, eliminate
and treat symptoms related to infections in lactating
animals during the lactation period; veterinary and
pharmaceutical preparations for increasing the welfare and
comfort of lactating animals, namely, to reduce, eliminate
and treat symptoms involved with the dry-off period in
lactating animals; pharmaceutical and medical preparations
for the prevention and treatment of lactation-related
medical conditions; pharmaceutical preparations, veterinary
preparations and medical preparations for the treatment and
prevention of infections, diseases, disorders and conditions
in poultry, and for promoting growth or the welfare of
poultry; pharmaceutical and medical preparations for the
prevention or treatment of buccal diseases, disorders and
conditions; pharmaceutical and medical preparations for the
prevention or treatment of central, peripherical and
neuronal nervous system conditions; pharmaceutical and
medical preparations for the prevention or treatment of
gastro-intestinal diseases, disorders and conditions;
pharmaceutical and medical preparations for the prevention
or treatment of diseases, disorders and conditions of the
skeletal system and the bones; medical and veterinary
preparations to regulate and adapt the mammalian gut
microbiome for disease prevention and wellness;
pharmaceutical preparations, medical preparations, and
veterinary preparations for the treatment of wounds, or
damages to the skin and tissues; pharmaceutical
preparations, medical preparations, and veterinary
preparations for the prevention and treatment of
dermatological disorders, or skin diseases, disorders and
conditions related to hyperactive immune response, or
allergic reactions and conditions; pharmaceutical
preparations, medical preparations, and veterinary
preparations for the prevention and treatment of medical
conditions and diseases associated with immunostimulation or
immunomodulation; synthetic and biological peptides for the
treatment of conditions and diseases associated with
immunostimulation, or for immunomodulation; pharmaceutical,
medical and veterinary preparations.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Intramammary and intrauterine veterinary preparations;
intramammary and intrauterine pharmaceutical and medical
preparations for human use; pharmaceutical preparations,
veterinary preparations, and medical preparations for the
treatment and prevention of mastitis, breast inflammation,
mammary infections, and mammary disorders; pharmaceutical
preparations, veterinary preparations, and medical
preparations for the treatment and prevention of metritis;
pharmaceutical preparations, veterinary preparations, and
medical preparations for the prevention and treatment of
uterine infections; veterinary preparations for increasing
milk production and improving feed efficiency; animal feed
additive for use as a nutritional supplement for medical
purposes; pharmaceutical and medical preparations for
increasing milk production; veterinary preparations for the
prevention and treatment of bacterial infections, disorders,
conditions, and diseases; pharmaceutical preparations and
medical preparations for the prevention and treatment of
bacterial infections, disorders, conditions, and diseases;
pharmaceutical preparations, veterinary preparations and
medical preparations for the involution of the udder or the
mammary gland; pharmaceutical preparations, veterinary
preparations and medical preparations for reduction of
somatic cell count; veterinary preparations, and
pharmaceutical preparations for increasing the welfare and
comfort of lactating animals, namely, to reduce, eliminate
and treat symptoms related to infections in lactating
animals during the lactation period; veterinary and
pharmaceutical preparations for increasing the welfare and
comfort of lactating animals, namely, to reduce, eliminate
and treat symptoms involved with the dry-off period in
lactating animals; pharmaceutical and medical preparations
for the prevention and treatment of lactation-related
medical conditions; pharmaceutical preparations, veterinary
preparations and medical preparations for the treatment and
prevention of infections, diseases, disorders and conditions
in poultry, and for promoting growth or the welfare of
poultry; pharmaceutical and medical preparations for the
prevention or treatment of buccal diseases, disorders and
conditions; pharmaceutical and medical preparations for the
prevention or treatment of central, peripherical and
neuronal nervous system conditions; pharmaceutical and
medical preparations for the prevention or treatment of
gastro-intestinal diseases, disorders and conditions;
pharmaceutical and medical preparations for the prevention
or treatment of diseases, disorders and conditions of the
skeletal system and the bones; medical and veterinary
preparations to regulate and adapt the mammalian gut
microbiome for disease prevention and wellness;
pharmaceutical preparations, medical preparations, and
veterinary preparations for the treatment of wounds, or
damages to the skin and tissues; pharmaceutical
preparations, medical preparations, and veterinary
preparations for the prevention and treatment of
dermatological disorders, or skin diseases, disorders and
conditions related to hyperactive immune response, or
allergic reactions and conditions; pharmaceutical
preparations, medical preparations, and veterinary
preparations for the prevention and treatment of medical
conditions and diseases associated with immunostimulation or
immunomodulation; synthetic and biological peptides for the
treatment of conditions and diseases associated with
immunostimulation, or for immunomodulation; pharmaceutical,
medical and veterinary preparations.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Intramammary and intrauterine veterinary preparations; intramammary and intrauterine pharmaceutical and medical preparations for human use; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections, and mammary disorders; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production; veterinary preparations for the prevention and treatment of bacterial infections, disorders, conditions, and diseases; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections, disorders, conditions, and diseases; pharmaceutical preparations, veterinary preparations and medical preparations for the involution of the udder or the mammary gland; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections, diseases, disorders and conditions in poultry, and for promoting growth or the welfare of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous system conditions; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases, disorders and conditions; pharmaceutical and medical preparations for the prevention or treatment of diseases, disorders and conditions of the skeletal system and the bones; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, or damages to the skin and tissues; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, or skin diseases, disorders and conditions related to hyperactive immune response, or allergic reactions and conditions; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of medical conditions and diseases associated with immunostimulation or immunomodulation; synthetic and biological peptides for the treatment of conditions and diseases associated with immunostimulation, or for immunomodulation; pharmaceutical, medical and veterinary preparations.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Intramammary and intrauterine veterinary preparations; intramammary and intrauterine pharmaceutical and medical preparations for human use; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections, and mammary disorders; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production; veterinary preparations for the prevention and treatment of bacterial infections, disorders, conditions, and diseases; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections, disorders, conditions, and diseases; pharmaceutical preparations, veterinary preparations and medical preparations for the involution of the udder or the mammary gland; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections, diseases, disorders and conditions in poultry, and for promoting growth or the welfare of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous system conditions; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases, disorders and conditions; pharmaceutical and medical preparations for the prevention or treatment of diseases, disorders and conditions of the skeletal system and the bones; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, or damages to the skin and tissues; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, or skin diseases, disorders and conditions related to hyperactive immune response, or allergic reactions and conditions; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of medical conditions and diseases associated with immunostimulation or immunomodulation; synthetic and biological peptides for the treatment of conditions and diseases associated with immunostimulation, or for immunomodulation; pharmaceutical, medical and veterinary preparations.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Intramammary and intrauterine veterinary preparations for treating mastitis, mammary infections, uterine infections, myometrium infection and intrauterine infections; intramammary and intrauterine pharmaceutical and medical preparations for human use for treating mastitis, mammary infections, and intrauterine infections; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections and mammary inflammation; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency, namely for treating gastro-intestinal diseases, anorexia, and for use as growth promoters; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production, namely for treating mastitis, mammary infections, and for involution of the mammary glands; veterinary preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations, veterinary preparations and medical preparations for mammary and udder involution; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count in milk, namely for treating mammary and udder inflammations; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals, namely for treating mammary pain, mammary infections, and edema; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions, namely for treating mammary pain, mammary infections, and edema; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections in poultry, and for use as growth promoters of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions, namely mucositis and buccal infections; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous systems diseases; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases; pharmaceutical and medical preparations for the prevention or treatment of diseases of the musculo-skeletal system; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, and damages to the skin and tissues, namely skin and tissue infections; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, and skin diseases, related to hyperactive immune response, or allergies; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of immunostimulation and immunomodulation; synthetic and biological peptides for the treatment of immunostimulation, and immunomodulation; pharmaceutical, medical and veterinary preparations to regulate and adapt the mammalian buccal, gastrointestinal and vaginal-vulvar microbiome for disease prevention and wellness
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Intramammary and intrauterine veterinary preparations for treating mastitis, mammary infections, uterine infections, myometrium infection and intrauterine infections; intramammary and intrauterine pharmaceutical and medical preparations for human use for treating mastitis, mammary infections, and intrauterine infections; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections and mammary inflammation; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency, namely for treating gastro-intestinal diseases, anorexia, and for use as growth promoters; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production, namely for treating mastitis, mammary infections, and for involution of the mammary glands; veterinary preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations, veterinary preparations and medical preparations for mammary and udder involution; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count in milk, namely for treating mammary and udder inflammations; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals, namely for treating mammary pain, mammary infections, and edema; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions, namely for treating mammary pain, mammary infections, and edema; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections in poultry, and for use as growth promoters of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions, namely mucositis and buccal infections; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous systems diseases; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases; pharmaceutical and medical preparations for the prevention or treatment of diseases of the musculo-skeletal system; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, and damages to the skin and tissues, namely skin and tissue infections; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, and skin diseases, related to hyperactive immune response, or allergies; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of immunostimulation and immunomodulation; synthetic and biological peptides for the treatment of immunostimulation, and immunomodulation; pharmaceutical, medical and veterinary preparations to regulate and adapt the mammalian buccal, gastrointestinal and vaginal-vulvar microbiome for disease prevention and wellness
11.
COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS
The present disclosure provides compositions and methods for modulating various mammary' disorders and conditions. The disclosure further provides a therapeutic combination of a composition of at least one casein protein or casein-derived peptide; and a teat seal composition.
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61K 31/29 - Composés de l'antimoine ou du bismuth
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
A61P 15/14 - Médicaments pour le traitement des troubles génitaux ou sexuelsContraceptifs pour les troubles de la lactation, p. ex. galactorrhée
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Veterinary preparations for use in livestock for the prevention and treatment of mastitis and mammary infections; veterinary and pharmaceutical preparations for the treatment and prevention of mastitis in livestock; animal production efficiency enhancing veterinary preparations to aid in milk production in lactating animals and improving feed efficiency; veterinary preparations for the prevention and treatment of intramammary infections; veterinary and pharmaceutical preparations for the involution of the mammary gland in livestock; veterinary and pharmaceutical preparations for shortening the dry-off period in livestock; veterinary and pharmaceutical preparations for reduction of somatic cell count in livestock; veterinary and pharmaceutical preparations for increasing the welfare and comfort of livestock, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in livestock
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Veterinary preparations for use in livestock for the prevention and treatment of mastitis and mammary infections; veterinary and pharmaceutical preparations for the treatment and prevention of mastitis in livestock; veterinary preparations for the prevention and treatment of intramammary infections; veterinary and pharmaceutical preparations for the involution of the mammary gland in livestock; veterinary and pharmaceutical preparations for reduction of somatic cell count in livestock; veterinary and pharmaceutical preparations for increasing the welfare and comfort of livestock, namely, to reduce, eliminate and treat symptoms related to infections in livestock during the lactation period
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Veterinary products, namely, preparations for use in
livestock; veterinary and pharmaceutical preparations for
the treatment and prevention of mastitis in livestock;
animal production efficiency enhancing veterinary
preparations for increasing milk production and improving
feed efficiency; intramammary veterinary preparations for
the prevention and treatment of bacterial infections,
disorders, conditions and diseases; veterinary and
pharmaceutical preparations for the involution of the
mammary gland in livestock; veterinary and pharmaceutical
preparations for shortening the dry-off period in livestock;
veterinary and pharmaceutical preparations for reduction of
somatic cell count in livestock; veterinary and
pharmaceutical preparations for increasing the welfare and
comfort of livestock, namely, to reduce, eliminate and treat
symptoms involved with the dry-off period in livestock.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Veterinary products, namely, preparations for use in
livestock; veterinary and pharmaceutical preparations for
the treatment and prevention of mastitis in livestock;
intramammary veterinary preparations for the prevention and
treatment of bacterial infections, disorders, conditions and
diseases; veterinary and pharmaceutical preparations for the
involution of the mammary gland in livestock; veterinary and
pharmaceutical preparations for reduction of somatic cell
count in livestock; veterinary and pharmaceutical
preparations for increasing the welfare and comfort of
livestock, namely, to reduce, eliminate and treat symptoms
related to infections in livestock during the lactation
period.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Veterinary and pharmaceutical preparations for the treatment and prevention of mastitis in livestock; animal production efficiency enhancing veterinary preparations for increasing milk production and improving feed efficiency; intramammary veterinary preparations for the prevention and treatment of bacterial infections, disorders, conditions and diseases; veterinary and pharmaceutical preparations for the involution of the mammary gland in livestock; veterinary and pharmaceutical preparations for shortening the dry-off period in livestock; veterinary and pharmaceutical preparations for reduction of somatic cell count in livestock; veterinary and pharmaceutical preparations for increasing the welfare and comfort of livestock, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in livestock
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Veterinary and pharmaceutical preparations for the treatment and prevention of mastitis in livestock; intramammary veterinary preparations for the prevention and treatment of bacterial infections, disorders, conditions and diseases; veterinary and pharmaceutical preparations for the involution of the mammary gland in livestock; veterinary and pharmaceutical preparations for reduction of somatic cell count in livestock; veterinary and pharmaceutical preparations for increasing the welfare and comfort of livestock, namely, to reduce, eliminate and treat symptoms related to infections in livestock during the lactation period
18.
Casein peptide for use in the treatment of uterine infections
The present disclosure relates to a casein peptide for use in the treatment of an uterine infection in a female mammalian animal, to methods of treatment of such infections by administering to a female mammalian animal at least one casein peptide, to the use of casein peptide for the preparation of a pharmaceutical composition for treatment of uterine infection and to a kit for said treatment. The casein peptide is preferably a casein hydrolysate, e.g. obtained by trypsin hydrolysis of casein protein. The female mammalian animal is, in accordance with some embodiments, a lactating animal, the infection being a post-partum infection.
A01N 37/18 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant trois liaisons à des hétéro-atomes, avec au plus deux liaisons à un halogène, p. ex. acides carboxyliques contenant le groupe —CO—N, p. ex. amides ou imides d'acide carboxyliqueLeurs thio-analogues
A61K 38/00 - Préparations médicinales contenant des peptides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
The present invention provides novel short peptides that are highly effective in inducing involution in a mammary gland of a lactating mammal and cessation of milk production by the gland. The invention further provides pharmaceutical composition comprising the peptides and methods of use thereof including for treating microbial infection in a mammary gland.
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
C07K 5/11 - Tétrapeptides la chaîne latérale du premier amino-acide contenant plus de groupes amino que de groupes carboxyle, ou leurs dérivés, p. ex. Lys, Arg
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
The present invention provides novel short peptides that are highly effective in inducing involution in a mammary gland of a lactating mammal and cessation of milk production by the gland. The invention further provides pharmaceutical composition comprising the peptides and methods of use thereof including for treating microbial infection in a mammary gland.
C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
21.
Casein peptide for use in the treatment of uterine infections
The present disclosure relates to a casein peptide for use in the treatment of an uterine infection in a female mammalian animal, to methods of treatment of such infections by administering to a female mammalian animal at least one casein peptide, to the use of casein peptide for the preparation of a pharmaceutical composition for treatment of uterine infection and to a kit for said treatment. The casein peptide is preferably a casein hydrolysate, e.g. obtained by trypsin hydrolysis of casein protein. The female mammalian animal is, in accordance with some embodiments, a lactating animal, the infection being a post-partum infection.
A01N 37/18 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des composés organiques comportant un atome de carbone possédant trois liaisons à des hétéro-atomes, avec au plus deux liaisons à un halogène, p. ex. acides carboxyliques contenant le groupe —CO—N, p. ex. amides ou imides d'acide carboxyliqueLeurs thio-analogues
A61K 38/00 - Préparations médicinales contenant des peptides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
The present disclosure relates to a casein peptide for use in the treatment of an uterine infection in a female mammalian animal, to methods of treatment of such infections by administering to a female mammalian animal at least one casein peptide, to the use of casein peptide for the preparation of a pharmaceutical composition for treatment of uterine infection and to a kit for said treatment. The casein peptide is preferably a casein hydrolysate, e.g. obtained by trypsin hydrolysis of casein protein. The female mammalian animal is, in accordance with some embodiments, a lactating animal, the infection being a post-partum infection.
State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research Organization (Israël)
Inventeur(s)
Iscovich, Jose Mario
Silanikove, Nissim
Iscovich, Javier
Abrégé
The present invention relates to peptides derived from casein and their use in the management of lactating animals, particularly to methods for decreasing the length of the dry period of a lactating livestock animal, for increasing its milk yield and milk hygiene after parturition and for improving the livestock welfare. The present invention further relates to pharmaceutical compositions comprising peptides derived from casein in the form of a sterile solution, which compositions are clear and substantially devoid of micelles.
The present invention relates to peptides derived from casein and their use in the management of lactating animals, particularly to methods for decreasing the length of the dry period of a lactating livestock animal, for increasing its milk yield and milk hygiene after parturition and for improving the livestock welfare. The present invention further relates to pharmaceutical compositions comprising peptides derived from casein in the form of a sterile solution, which compositions are clear and substantially devoid of micelles.
STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (Israël)
Inventeur(s)
Iscovich, Jose Mario
Abrégé
The present invention relates to methods for controlling the reproductive cycles and weaning in livestock, particularly to the use of casein-derived peptides for estrus induction and reduction of anestrus intervals, enabling early weaning without negatively affecting the livestock welfare. The present invention further relates to estrus synchronization in a livestock herd and to livestock management programs.
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du lait, p. ex. caséinePréparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (Israël)
Inventeur(s)
Iscovich, Jose Mario
Silanikove, Nissim
Iscovich, Javier
Abrégé
The present invention relates to peptides derived from casein and their use in the management of lactating animals, particularly to methods for decreasing the length of the dry period of a lactating livestock animal, for increasing its milk yield and milk hygiene after parturition and for improving the livestock welfare. The present invention further relates to pharmaceutical compositions comprising peptides derived from casein in the form of a sterile solution, which compositions are clear and substantially devoid of micelles.
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
27.
CASEIN PEPTIDE FOR USE IN THE TREATMENT OF UTERINE INFECTIONS
The present disclosure relates to a casein peptide for use in the treatment of an uterine infection in a female mammalian animal, to methods of treatment of such infections by administering to a female mammalian animal at least one casein peptide, to the use of casein peptide for the preparation of a pharmaceutical composition for treatment of uterine infection and to a kit for said treatment. The casein peptide is preferably a casein hydrolysate, e.g. obtained by trypsin hydrolysis of casein protein. The female mammalian animal is, in accordance with some embodiments, a lactating animal, the infection being a post-partum infection.
The present invention provides novel short peptides that are highly effective in inducing involution in a mammary gland of a lactating mammal and cessation of milk production by the gland. The invention further provides pharmaceutical composition comprising the peptides and methods of use thereof including for treating microbial infection in a mammary gland.
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
29.
COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A23C 9/00 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre
A23C 9/12 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes
A23C 9/142 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
A23C 9/20 - Produits diététiques à base de lait non couverts par les groupes
A23C 19/05 - Traitement du lait avant le caillageSéparation du petit-lait du lait caillé
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du lait, p. ex. caséinePréparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
A61K 38/08 - Peptides ayant de 5 à 11 amino-acides
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C07K 5/103 - Tétrapeptides la chaîne latérale du premier amino-acide étant acyclique, p. ex. Gly, Ala
C07K 5/11 - Tétrapeptides la chaîne latérale du premier amino-acide contenant plus de groupes amino que de groupes carboxyle, ou leurs dérivés, p. ex. Lys, Arg
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
